Skip to content
10-Q

Quarterly Report

ProKidney Corp. PROK

0001193125-25-274303

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Capex Q3 2025 · Sep 30, 2025 $9.44M
Capex Q3 2025 · Sep 30, 2024 $4M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$87.6M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$102.18M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $95.32M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $99.12M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$1.01B
Stockholders Equity Q3 2025 · Jun 30, 2025 −$1B
Stockholders Equity Q3 2025 · Dec 31, 2024 −$994.95M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$979.71M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$972.37M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$1.1B
Current Liabilities Q3 2025 · Sep 30, 2025 $29.06M
Current Liabilities Q3 2025 · Dec 31, 2024 $36.22M
Total Liabilities Q3 2025 · Sep 30, 2025 $33.27M
Total Liabilities Q3 2025 · Dec 31, 2024 $39.44M
Current Assets Q3 2025 · Sep 30, 2025 $299.99M
Current Assets Q3 2025 · Dec 31, 2024 $395.88M
Total Assets Q3 2025 · Sep 30, 2025 $351.61M
Total Assets Q3 2025 · Dec 31, 2024 $441.07M
Sga Expense Q3 2025 · Sep 30, 2025 $11.94M
Sga Expense Q3 2025 · Sep 30, 2025 $40.34M
Sga Expense Q3 2025 · Sep 30, 2024 $17.72M
Sga Expense Q3 2025 · Sep 30, 2024 $44.22M
Rd Expense Q3 2025 · Sep 30, 2025 $26.82M
Rd Expense Q3 2025 · Sep 30, 2025 $79.97M
Rd Expense Q3 2025 · Sep 30, 2024 $31.25M
Rd Expense Q3 2025 · Sep 30, 2024 $87.89M
Net Income Q3 2025 · Sep 30, 2025 −$16.47M
Net Income Q3 2025 · Sep 30, 2025 −$49.76M
Net Income Q3 2025 · Sep 30, 2024 −$17.91M
Net Income Q3 2025 · Sep 30, 2024 −$39.91M
Operating Income Q3 2025 · Sep 30, 2025 −$38.54M
Operating Income Q3 2025 · Sep 30, 2025 −$119.64M
Operating Income Q3 2025 · Sep 30, 2024 −$48.97M
Operating Income Q3 2025 · Sep 30, 2024 −$132.11M
Revenue Q3 2025 · Sep 30, 2025 $217K
Revenue Q3 2025 · Sep 30, 2025 $668K
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $0